Figure 1.
Hb response after the initiation of daratumumab therapy. (A) Patients with wAIHA. (B) Patients with cAIHA. Gray lines represent individual data of Hb; bold line represents median Hb over time.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.